The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: A pilot study.
Nicholas Fidelman
Research Funding - Bayer; Nordion
Robert Keith Kerlan
No relevant relationships to disclose
Randall A. Hawkins
No relevant relationships to disclose
Emily K. Bergsland
No relevant relationships to disclose
Robin Kate Kelley
No relevant relationships to disclose
Andrew H. Ko
No relevant relationships to disclose
Wolfgang Michael Korn
No relevant relationships to disclose
Alan Paul Venook
No relevant relationships to disclose